IRIS
GIALLONGO, CESARINA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.019
EU - Europa 2.396
AS - Asia 1.567
AF - Africa 273
SA - Sud America 248
OC - Oceania 5
Continente sconosciuto - Info sul continente non disponibili 2
Totale 7.510
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.945
IT - Italia 1.534
SG - Singapore 654
CN - Cina 597
IE - Irlanda 287
BR - Brasile 221
CI - Costa d'Avorio 205
UA - Ucraina 135
KR - Corea 112
DE - Germania 103
CA - Canada 61
RU - Federazione Russa 59
VN - Vietnam 53
FI - Finlandia 49
SN - Senegal 49
FR - Francia 43
GB - Regno Unito 43
IN - India 41
SE - Svezia 34
JP - Giappone 25
CZ - Repubblica Ceca 23
NL - Olanda 20
BE - Belgio 15
HK - Hong Kong 13
BD - Bangladesh 12
CH - Svizzera 12
EC - Ecuador 11
MX - Messico 11
PL - Polonia 11
AR - Argentina 7
LB - Libano 7
UZ - Uzbekistan 7
AE - Emirati Arabi Uniti 6
IL - Israele 6
NG - Nigeria 6
TR - Turchia 6
ES - Italia 5
GR - Grecia 5
IQ - Iraq 5
MA - Marocco 5
AT - Austria 4
AU - Australia 4
PK - Pakistan 4
NO - Norvegia 3
NP - Nepal 3
AL - Albania 2
BO - Bolivia 2
LT - Lituania 2
OM - Oman 2
PT - Portogallo 2
SA - Arabia Saudita 2
TN - Tunisia 2
UY - Uruguay 2
VE - Venezuela 2
ZA - Sudafrica 2
AM - Armenia 1
AZ - Azerbaigian 1
CL - Cile 1
CO - Colombia 1
DZ - Algeria 1
EG - Egitto 1
ET - Etiopia 1
EU - Europa 1
GE - Georgia 1
HN - Honduras 1
HR - Croazia 1
IR - Iran 1
JO - Giordania 1
KE - Kenya 1
KG - Kirghizistan 1
KH - Cambogia 1
KZ - Kazakistan 1
MK - Macedonia 1
NI - Nicaragua 1
PG - Papua Nuova Guinea 1
PH - Filippine 1
PS - Palestinian Territory 1
PY - Paraguay 1
RO - Romania 1
RS - Serbia 1
SI - Slovenia 1
SY - Repubblica araba siriana 1
TH - Thailandia 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 7.510
Salva come PNG Salva come JPEG
Città #
Santa Clara 646
Singapore 467
Chandler 453
Catania 418
Chicago 287
Dublin 284
Hefei 213
Abidjan 204
Jacksonville 156
Ashburn 132
Boardman 123
Seoul 112
Beijing 102
Civitanova Marche 91
Florence 85
Houston 74
Cambridge 68
Lawrence 68
Andover 64
Rome 63
Los Angeles 58
Dakar 49
Milan 46
Dong Ket 44
Munich 43
Nanjing 42
Palermo 38
Toronto 38
Des Moines 36
Bronte 26
Misterbianco 26
Bremen 25
Wilmington 24
Messina 23
Bari 22
Council Bluffs 20
The Dalles 20
Brno 19
Helsinki 19
Saint Petersburg 19
San Mateo 19
Falls Church 18
Nanchang 18
Shenyang 17
Turku 16
Washington 16
Columbus 15
Dearborn 14
Fukuoka 14
Lappeenranta 14
Paris 14
São Paulo 14
Brussels 13
Hong Kong 13
Turin 13
Brooklyn 12
Hebei 12
Kochi 12
Augusta 11
New York 11
Ottawa 11
Moscow 10
Seattle 10
Tokyo 10
Warsaw 10
Changsha 9
Dallas 9
Guangzhou 9
Jiaxing 9
Aci Catena 8
Acireale 8
Boston 8
Chennai 8
Tianjin 8
Genoa 7
Hanover 7
Ragusa 7
San Giovanni la Punta 7
Abuja 6
Amsterdam 6
Den Haag 6
Hanoi 6
Mascalucia 6
Modica 6
San Francisco 6
Torino 6
Vicenza 6
Belpasso 5
Charlotte 5
Floridia 5
Grafing 5
Jinan 5
London 5
Montreal 5
Naples 5
Padova 5
Pozzallo 5
Rio de Janeiro 5
Aachen 4
Agrate Brianza 4
Totale 5.305
Salva come PNG Salva come JPEG
Nome #
Activity-Dependent Neuroprotective Protein (ADNP)-Derived Peptide (NAP) Counteracts UV-B Radiation-Induced ROS Formation in Corneal Epithelium 174
α-Lipoic Acid Reduces Iron-induced Toxicity and Oxidative Stress in a Model of Iron Overload 165
Heme oxygenase-1 nuclear translocation regulates bortezomib-induced cytotoxicity and mediates genomic instability in myeloma cells. 142
Biological properties of Cakile maritima Scop. (Brassicaceae) extracts 138
CXCL12/CXCR4 axis supports mitochondrial trafficking in tumor myeloma microenvironment 128
Heme Oxygenase Inhibition Sensitizes Neuroblastoma Cells to Carfilzomib 118
Antimicrobial and anti-proliferative effects of skin mucus derived from dasyatis pastinaca (Linnaeus, 1758) 117
Inhibition of TLR4 signaling affects mitochondrial fitness and overcomes bortezomib resistance in myeloma plasma cells 115
Biological properties of itraconazole-SLN 111
Clobetasol promotes neuromuscular plasticity in mice after motoneuronal loss via sonic hedgehog signaling, immunomodulation and metabolic rebalancing 109
Anaplastic thyroid cancer cells reduce CD71 levels to increase iron overload tolerance 107
Focus on Osteosclerotic Progression in Primary Myelofibrosis 102
Mesenchymal stromal cells in tumor microenvironment remodeling of BCR-ABL negative myeloproliferative diseases 101
Clobetasol modulates adult neural stem cell growth via canonical hedgehog pathway activation 101
Effect of lipoic acid on the biochemical mechanisms of resistance to bortezomib in SH-SY5Y neuroblastoma cells 98
Ixazomib improves bone remodeling and counteracts sonic hedgehog signaling inhibition mediated by myeloma cells 98
ACVR1: A Novel Therapeutic Target to Treat Anemia in Myelofibrosis 96
Antiproliferative and Antiangiogenic Effects of Punica granatum Juice (PGJ) in Multiple Myeloma (MM) 95
Bortezomib modulates CHIT1 and YKL40 in monocyte-derived osteoclast and in myeloma cells. 94
Monocytic myeloid-derived suppressor cells as prognostic factor in chronic myeloid leukaemia patients treated with dasatinib 94
Mitochondrial Functions, Energy Metabolism and Protein Glycosylation are Interconnected Processes Mediating Resistance to Bortezomib in Multiple Myeloma Cells 94
Glioblastoma mesenchymal subtype enhances antioxidant defence to reduce susceptibility to ferroptosis 93
Immune off-target effects of Brentuximab Vedotin in relapsed/refractory Hodgkin Lymphoma 92
Lactate modulates microglia polarization via IGFBP6 expression and remodels tumor microenvironment in glioblastoma 91
Hedgehog signaling pathways in multiple myeloma 91
A cytoprotective role for the heme oxygenase-1/CO pathway during neural differentiation of human mesenchymal stem cells 91
Lactate Induces the Expressions of MCT1 and HCAR1 to Promote Tumor Growth and Progression in Glioblastoma 90
In-vitro NET-osis induced by COVID-19 sera is associated to severe clinical course in not vaccinated patients and immune-dysregulation in breakthrough infection 89
Role of 17β-Estradiol on Cell Proliferation and Mitochondrial Fitness in Glioblastoma Cells 88
Chitinase domain containing 1 increase is associated with low survival rate and M0 macrophages infiltrates in colorectal cancer patients 86
Iron regulates myeloma cell/macrophage interaction and drives resistance to bortezomib 86
Lactate Rewrites the Metabolic Reprogramming of Uveal Melanoma Cells and Induces Quiescence Phenotype 85
TLR4 signaling drives mesenchymal stromal cells commitment to promote tumor microenvironment transformation in multiple myeloma 85
SPARC expression in CML is associated to imatinib treatment and to inhibition of leukemia cell proliferation 84
Biochemical and clinical relevance of alpha lipoic acid: antioxidant and anti-inflammatory activity, molecular pathways and therapeutic potential 84
Targeted Metabolomics Highlights Dramatic Antioxidant Depletion, Increased Oxidative/Nitrosative Stress and Altered Purine and Pyrimidine Concentrations in Serum of Primary Myelofibrosis Patients 83
PMN-MDSC and arginase are increased in myeloma and may contribute to resistance to therapy 82
High-density neutrophils in MGUS and multiple myeloma are dysfunctional and immune-suppressive due to increased STAT3 downstream signaling 81
Effects of second-generation tyrosine kinase inhibitors towards osteogenic differentiation of human mesenchymal cells of healthy donors 80
Bortezomib Inhibits Osteoclastogenesis and Bone Resorption Through Modulation of CHIT1 and YKL40 Expression 80
Clinical outcome of SARS-CoV-2 infections occurring in multiple myeloma patients after vaccination and prophylaxis with tixagevimab/cilgavimab 79
Correction: TLR4 signaling drives mesenchymal stromal cells commitment to promote tumor microenvironment transformation in multiple myeloma (Cell Death & Disease, (2019), 10, 10, (704), 10.1038/s41419-019-1959-5) 79
Plasticity of High-Density Neutrophils in Multiple Myeloma is Associated with Increased Autophagy via STAT3 79
Biological properties of itraconazole-SLNs 78
The Role of Epigenetics in Neuroinflammatory-Driven Diseases 77
Effects of imatinib mesylate in osteoblastogenesis 77
BORTEZOMIB INHIBITS OSTEOCLASTOGENESIS AND MODULATE CHIT1 AND YKL40 EXPRESSION 76
Pericytes in microvessels: From “mural” function to brain and retina regeneration 75
Ruxolitinib treatment in myelofibrosis and polycythemia vera causes suboptimal humoral immune response following standard and booster vaccination with BNT162b2 mRNA COVID-19 vaccine 74
Mesenchymal Stem Cells (MSC) Regulate Activation of Granulocyte-Like Myeloid Derived Suppressor Cells (G-MDSC) in Chronic Myeloid Leukemia Patients 74
Electronic nicotine delivery systems exhibit reduced bronchial epithelial cells toxicity compared to cigarette: the Replica Project 74
Neuroprotective Role of α-Lipoic Acid in Iron-Overload-Mediated Toxicity and Inflammation in In Vitro and In Vivo Models 73
Lactate trafficking inhibition restores sensitivity to proteasome inhibitors and orchestrates immuno-microenvironment in multiple myeloma 73
Bortezomib Could Reduce Cell Viability by Activation of Heme Oxygenase 1 in Multiple Myeloma Cells 72
Concomitant and feasible treatment with dasatinib and the anti-EGFR antibody cetuximab plus radiotherapy in a CML patient with multiple squamous neoplasias 72
CIRCULATING ARGINASE-1 IN SERUM IS A NOVEL BIO-MARKERIN HODGKIN LYMPHOMA 69
Clinical impact of the immunome in lymphoid malignancies: the role of Myeloid-Derived Suppressor Cells 67
Myelofibrosis and Survival Prognostic Models: A Journey between Past and Future 66
Modulation of extracellular signal-related kinase, cyclin D1, glial fibrillary acidic protein, and vimentin expression in estradiol-pretreated astrocyte cultures treated with competence and progression growth factors 66
The Heme Oxygenase System in Hematological Malignancies 66
Proteomic analysis reveals autophagy as pro-survival pathway elicited by long-term exposure with 5-azacitidine in high-risk myelodysplasia 66
MONOCYTIC MYELOID DERIVED SUPPRESSOR CELLS (M-MDSC) AS PROGNOSTIC FACTOR IN DASATINIB TREATED PATIENTS WITH CHRONIC MYELOID LEUKEMIA 65
MacroH2A1.1 as a crossroad between epigenetics, inflammation and metabolism of mesenchymal stromal cells in myelodysplastic syndromes 64
Neuroactive molecules and growth factors modulate cytoskeletal protein expression during astroglial cell proliferation and differentiation in culture 64
BRIT1/MCPH1 expression in chronic myeloid leukemia and its regulation of the G2/M checkpoint. 64
Nuclear translocation of Heme oxygenase-1 confers resistance to imatinib in chronic myeloid leukemia cells 63
Myeloid-derived suppressor cells in Chronic myeloid leukemia 63
Prediction of Survival and Prognosis Migration from Gold-Standard Scores in Myelofibrosis Patients Treated with Ruxolitinib Applying the RR6 Prognostic Model in a Monocentric Real-Life Setting 62
Correction to: Neuroprotective Role of α-Lipoic Acid in Iron-Overload-Mediated Toxicity and Inflammation in In Vitro and In Vivo Models (Antioxidants, (2022), 11, 8, (1596), 10.3390/antiox11081596) 62
Engagement of Mesenchymal Stromal Cells in the Remodeling of the Bone Marrow Microenvironment in Hematological Cancers 62
Mitochondrial Bioenergetics at the Onset of Drug Resistance in Hematological Malignancies: An Overview 61
BRIT1/MCPH1 expression in chronic myeloid leukemia and its regulation of the G2/M checkpoint 60
GRANULOCYTE-LIKE MYELOID DERIVED SUPPRESSOR CELLS ARE INCREASED IN MULTIPLE MYELOMA DUE TO IMMUNOLOGICAL DYSREGULATION OF MESENCHYMAL STEM CELLS 58
Immune Response and Breakthrough Infection Risk After SARS-CoV-2 Vaccines in Patients with Hemoglobinopathy: A Single Center Experience 57
TLR4 Signaling and Heme Oxygenase-1/Carbon Monoxide Pathway Crosstalk Induces Resiliency of Myeloma Plasma Cells to Bortezomib Treatment 56
The prognostic value of the myeloid-mediated immunosuppression marker Arginase-1 in classic Hodgkin lymphoma. 56
OVEREXPRESSION OF ARGINASE AND PROK-2 MAKES NEUTROPHILS OF MULTIPLE MYELOMA DYSFUNCTIONAL AND IMMUNOSUPPRESSIVE 54
IMPAIRED NEUTROPHIL FUNCTION IN PATIENTS WITH ACUTE LEUKEMIA 52
Proteasome inhibitors as a possible therapy for SARS-CoV-2 52
LENALIDOMIDE TREATMENT IS ABLE TO RESTORE REGULATORY T CELLS IN MULTIPLE MYELOMA PATIENTS 51
The Role of Inflammation and Inflammasome in Myeloproliferative Disease 50
IGFBP-6/sonic hedgehog/TLR4 signalling axis drives bone marrow fibrotic transformation in primary myelofibrosis 49
Lactate accumulation promotes immunosuppression and fibrotic transformation of bone marrow microenvironment in myelofibrosis 48
Myeloid derived suppressor cells (MDSCs) are increased and exert immunosuppressive activity together with polymorphonuclear leukocytes (PMNs) in chronic myeloid leukemia patients 48
The pharmacotherapeutic management of patients with myelofibrosis: looking beyond JAK inhibitors 47
The Pleiotropic Effects of Fumarate: From Mitochondrial Respiration to Epigenetic Rewiring and DNA Repair Mechanisms 47
Immunoproteasome Genes Are Modulated in CD34+ JAK2V617F Mutated Cells from Primary Myelofibrosis Patients 47
Purine metabolism rewiring improves glioblastoma susceptibility to temozolomide treatment 46
Monocytic myeloid derived suppressor cells in hematological malignancies 46
Pituitary Adenylate Cyclase-Activating Polypeptide Protects Corneal Epithelial Cells against UV-B-Induced Apoptosis via ROS/JNK Pathway Inhibition 46
Imatinib increases cytotoxicity of melphalan and their combination allows an efficient killing of chronic myeloid leukemia cells 44
MESENCHYMAL STEM CELLS FROM CML PATIENTS REGULATE MYELOID DERIVED SUPPRESSOR CELLS ACTIVATION 43
IGFBP-6: At the Crossroads of Immunity, Tissue Repair and Fibrosis 43
Overexpression of heme oxygenase-1 increases human osteoblast stem cell differentiation. 43
Granulocyte-like myeloid derived suppressor cells (G-MDSC) are increased in multiple myeloma and are driven by dysfunctional mesenchymal stem cells (MSC) 40
Deficiency and haploinsufficiency of histone macroH2A1.1 in mice recapitulate hematopoietic defects of human myelodysplastic syndrome 40
Uveal melanoma cells elicit retinal pericyte phenotypical and biochemical changes in an in vitro model of coculture 40
Ixazomib inhibits osteoclastogenesis and promotes osteogenic differentiation in vitro 39
Immune responses to oligomeric α-synuclein in Parkinson’s disease peripheral blood mononuclear cells 37
Targeted metabolomic evaluation of peripheral blood mononucleated cells from patients with PMM2-CDG 33
Totale 7.572
Salva come PNG Salva come JPEG
Categoria #
all - tutte 29.531
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 29.531
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021447 0 19 35 32 111 16 61 11 30 7 49 76
2021/2022653 41 77 10 4 116 26 101 49 51 31 18 129
2022/20231.368 96 112 40 144 111 188 19 237 267 44 71 39
2023/2024928 55 140 39 40 47 203 40 88 4 25 168 79
2024/20252.886 42 456 155 198 522 357 157 136 175 226 242 220
2025/2026749 417 332 0 0 0 0 0 0 0 0 0 0
Totale 7.713